8622 — Huakang Biomedical Holdings Co Share Price
0.000.00%
Last trade - 00:00- HK$59.62m
- HK$26.43m
- CNY24.63m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.08 | ||
| Price to Tang. Book | 1.13 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 2.24 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -10.97% | ||
| Return on Equity | -10.75% | ||
| Operating Margin | -23.26% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CNYm | 25.47 | 21.97 | 26.13 | 25.33 | 24.63 | n/a | n/a | -3% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Huakang Biomedical Holdings Co Ltd is an investment holding company mainly engaged in the production and sales of in-vitro diagnostic reagents. The Company operates its business through two segments. The Biological Reagents and Auxiliary Reproductive Supplies and Equipment segment is engaged in the research and development, production, marketing and sales of in-vitro diagnostic reagents, including male infertility in vitro diagnostic reagents, parasite series detection reagents and Epstein-Barr (EB) virus detection reagents. The Segment is also engaged in the manufacture and sale of auxiliary reproductive supplies and devices. The Healthcare Products and Supplements segment is engaged in the sales of health products and supplements.
Directors
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- August 3rd, 2017
- Public Since
- December 13th, 2018
- No. of Employees
- 96
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- Stock Exchange of Hong Kong Limited
- Shares in Issue
- 469,472,000
- Address
- 2/F, 100 Des Voeux Road Central, Central
- Web
- http://www.huakangbiomedical.com/
- Phone
- +852 null22028989
- Auditors
- Mazars CPA Limited
Upcoming Events for 8622
Similar to 8622
Acotec Scientific Holdings
Stock Exchange of Hong Kong Limited
Beijing Airdoc Technology Co
Stock Exchange of Hong Kong Limited
AK Medical Holdings
Stock Exchange of Hong Kong Limited
AMCO United Holding
Stock Exchange of Hong Kong Limited
Angelalign Technology
Stock Exchange of Hong Kong Limited
FAQ
What is the Huakang Biomedical Holdings Co share price?
As of Today at 19:10 UTC, shares in Huakang Biomedical Holdings Co are trading at HK$0.13. This share price information is delayed by 15 minutes.
How has the Huakang Biomedical Holdings Co share price performed this year?
Shares in Huakang Biomedical Holdings Co last closed at HK$0.13 and the price had moved by -23.49% over the past 365 days. In terms of relative price strength the Huakang Biomedical Holdings Co share price has underperformed the FTSE Developed Asia Pacific Index by -22.97% over the past year.
What are the analyst and broker recommendations for Huakang Biomedical Holdings Co?
There is no consensus recommendation for this security.
What is the Huakang Biomedical Holdings Co dividend yield?
Huakang Biomedical Holdings Co does not currently pay a dividend.
Does Huakang Biomedical Holdings Co pay a dividend?
Huakang Biomedical Holdings Co does not currently pay a dividend.
When does Huakang Biomedical Holdings Co next pay dividends?
Huakang Biomedical Holdings Co does not currently pay a dividend.
How do I buy Huakang Biomedical Holdings Co shares?
To buy shares in Huakang Biomedical Holdings Co you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Huakang Biomedical Holdings Co?
As of the previous close price of HK$0.13, shares in Huakang Biomedical Holdings Co had a market capitalisation of HK$59.62m.
Where are Huakang Biomedical Holdings Co shares listed?
Here are the trading details for Huakang Biomedical Holdings Co:
- Country of listing: Hong Kong
- Exchange: HKG
- Ticker Symbol: 8622
What kind of share is Huakang Biomedical Holdings Co?
Based on an overall assessment of its quality, value and momentum Huakang Biomedical Holdings Co is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Huakang Biomedical Holdings Co share price forecast for 2024?
We could not find analyst target price data for this security.
What is the trend in the Huakang Biomedical Holdings Co share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Huakang Biomedical Holdings Co. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -7.87%.
As of the last closing price of HK$0.13, shares in Huakang Biomedical Holdings Co were trading -8.21% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Huakang Biomedical Holdings Co PE Ratio?
The Huakang Biomedical Holdings Co PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at HK$0.13.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Huakang Biomedical Holdings Co?
We do not have data on Huakang Biomedical Holdings Co's directors